CollaGenex' Oracea Rosacea Therapy Could Launch Third Quarter 2006
Firm announces NDA submission for the rosacea therapy. As the first oral systemic rosacea treatment, Oracea could expand the market, CollaGenex says.
Firm announces NDA submission for the rosacea therapy. As the first oral systemic rosacea treatment, Oracea could expand the market, CollaGenex says.